Literature DB >> 17697862

The effect of renal transplantation on adiponectin and its isoforms and receptors.

Yvonne Y Shen1, John A Charlesworth, John J Kelly, Philip W Peake.   

Abstract

Insulin resistance (IR) and other proatherogenic risk factors associated with end-stage kidney disease (ESKD) are improved by renal transplantation. Adiponectin is a protein with insulin-sensitizing, anti-inflammatory, and antiatherogenic properties. It exists in several isoforms, but the high molecular weight (HMW) isoform correlates best with insulin sensitivity. Paradoxically, the levels of this protein and its HMW isoform are increased in ESKD. We measured the homeostasis model assessment for insulin resistance (HOMA-IR), plasma adiponectin and its isoforms, and messenger RNA for adiponectin receptors (AdipoR1 and AdipoR2) on peripheral blood mononuclear cells in 54 stable transplant recipients, 50 patients established on hemodialysis, and 52 controls; groups were matched for body mass index and sex. HOMA-IR values were significantly higher in patients with ESKD compared with controls (P < .0005) and transplant patients (P < .05) but there was no difference between the latter 2 groups. Adiponectin levels were also higher in patients with ESKD compared with controls (P < .0005), and although levels were lower in the transplant group, they remained higher than in controls (P < .0001). However, although the absolute amount of HMW isoform in transplant patients remained higher than in controls (P < .0001), the proportion was similar, and less than in patients with ESKD (P < .005). The absolute amount of the HMW isoform correlated with superior metabolic indices in all 3 cohorts. AdipoR1 and AdipoR2 messenger RNA levels after transplantation were significantly lower than those of ESKD subjects (P < .0001, P < .01), but transplant patients had less AdipoR1 than controls, although their AdipoR2 levels were higher. AdipoR1 correlated with AdipoR2 in all 3 cohorts. We conclude that HOMA-IR was lower in the transplant group compared with the group on hemodialysis and this coincided with lower total adiponectin levels and absolute amount of the HMW isoform and AdipoR on peripheral blood mononuclear cells. Lower AdipoR after transplantation may be secondary to immunosuppression and/or an improvement in glomerular filtration rate and the uremic milieu.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17697862     DOI: 10.1016/j.metabol.2007.04.016

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  11 in total

Review 1.  Adipokines protecting CKD.

Authors:  Satoshi Miyamoto; Kumar Sharma
Journal:  Nephrol Dial Transplant       Date:  2013-11       Impact factor: 5.992

2.  Association of Adiponectin With Body Composition and Mortality in Hemodialysis Patients.

Authors:  Connie M Rhee; Danh V Nguyen; Hamid Moradi; Steven M Brunelli; Ramanath Dukkipati; Jennie Jing; Tracy Nakata; Csaba P Kovesdy; Gregory A Brent; Kamyar Kalantar-Zadeh
Journal:  Am J Kidney Dis       Date:  2015-03-29       Impact factor: 8.860

3.  Adiponectin receptor and adiponectin signaling in human tissue among patients with end-stage renal disease.

Authors:  Maria P Martinez Cantarin; Scott W Keith; Scott A Waldman; Bonita Falkner
Journal:  Nephrol Dial Transplant       Date:  2014-07-21       Impact factor: 5.992

4.  High serum adiponectin concentration in children with chronic kidney disease.

Authors:  Kristina F Möller; Christina Dieterman; Lena Herich; Ilka A Klaassen; Markus J Kemper; Dirk E Müller-Wiefel
Journal:  Pediatr Nephrol       Date:  2011-08-09       Impact factor: 3.714

Review 5.  Clinical review: adiponectin biology and its role in inflammation and critical illness.

Authors:  Katherine Robinson; John Prins; Bala Venkatesh
Journal:  Crit Care       Date:  2011-04-20       Impact factor: 9.097

Review 6.  Adipocytokines in renal transplant recipients.

Authors:  Kristof Nagy; Shankar Prasad Nagaraju; Connie M Rhee; Zoltan Mathe; Miklos Z Molnar
Journal:  Clin Kidney J       Date:  2016-03-15

7.  Adiponectin Fractions Influence the Development of Posttransplant Diabetes Mellitus and Cardiovascular Disease in Japanese Renal Transplant Recipients.

Authors:  Hiroki Adachi; Kanae Nakayama; Norifumi Hayashi; Yuki Matsui; Keiji Fujimoto; Hideki Yamaya; Hisao Tonami; Hitoshi Yokoyama
Journal:  PLoS One       Date:  2016-10-05       Impact factor: 3.240

8.  The adipose tissue production of adiponectin is increased in end-stage renal disease.

Authors:  Maria P Martinez Cantarin; Scott A Waldman; Cataldo Doria; Adam M Frank; Warren R Maley; Carlo B Ramirez; Scott W Keith; Bonita Falkner
Journal:  Kidney Int       Date:  2013-01-02       Impact factor: 10.612

9.  Lower total and percent of high-molecular-weight adiponectin concentration in South Asian kidney transplant recipients.

Authors:  G V Ramesh Prasad; Leon Vorobeichik; Michelle M Nash; Michael Huang; Lindita Rapi; Graham Maguire; Muhammad Mamdani; Andrew T Yan; Philip W Connelly
Journal:  Clin Kidney J       Date:  2012-04

Review 10.  The complex effects of adipokines in the patients with kidney disease.

Authors:  Sahar Vahdat
Journal:  J Res Med Sci       Date:  2018-07-26       Impact factor: 1.852

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.